Increase in the iron content of the substantia nigra and red nucleus in multiple sclerosis and clinically isolated syndrome: A 7 Tesla MRI study

Journal of Magnetic Resonance Imaging

Volumn 41, Issue 4, 2015, Pages 1065-1070

  Blazejewska, Anna I ^a   Al Radaideh, Ali M ^b   Wharton, Sam ^a   Lim, Su Yin ^a   Bowtell, Richard W ^a   Constantinescu, Cris S ^a   Gowland, Penny A ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b HASHEMITE UNIVERSITY   (Jordan)

Author keywords

clinically isolated syndrome; gray matter; magnetic resonance imaging; multiple sclerosis; red nucleus; substantia nigra

Indexed keywords

IRON; BIOLOGICAL MARKER;

ADULT; ARTICLE; BRAIN MAPPING; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATING DISEASE; ECHO PLANAR IMAGING; EXPANDED DISABILITY STATUS SCALE; HUMAN; MAGNETISM; MULTIPLE SCLEROSIS; NEUROMONITORING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RED NUCLEUS; REGION OF INTEREST; STATISTICAL PARAMETERS; SUBSTANTIA NIGRA; COMPARATIVE STUDY; FEMALE; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION; UPREGULATION;

ADULT; BIOMARKERS; DEMYELINATING DISEASES; FEMALE; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RED NUCLEUS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBSTANTIA NIGRA; TISSUE DISTRIBUTION; UP-REGULATION;

EID: 84925305638     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24644     Document Type: Article

References (34)

1. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69: 292-302.
2. Barkhof F,. MRI in multiple sclerosis: correlation with expanded disability status scale (EDSS). Mult Scler 1999; 5: 283-286.
3. Kappos L, Moeri D, Radue EW, et al. Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group. Lancet 1999; 353: 964-969.
4. Filippi M, Rocca MA, De Stefano N, et al. Magnetic Resonance Techniques in Multiple Sclerosis. Arch Neurol 2011; 68: 1514-1520.
5. Drayer B, Burger P, Hurwitz B, et al. Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content? AJR Am J Roentgenol 1987; 149: 357-363.
6. Bakshi R, Benedict RHB, Bermel RA, et al. T2 Hypointensity in the deep gray matter of patients with multiple sclerosis. Arch Neurol 2002; 59: 62-68.
7. Khalil M, Enzinger C, Langkammer C, et al. Quantitative assessment of brain iron by R(2)∗ relaxometry in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis. Mult Scler 2009; 15: 1048-1054.
8. Zhang Y, Zabad RK, Wei X, et al. Deep grey matter "black T2" on 3 Tesla magnetic resonance imaging correlates with disability in multiple sclerosis. Mult Scler 2007; 13: 880-883.
9. Zhang Y, Metz LM, Yong VW, et al. 3T deep gray matter T2 hypointensity correlates with disability over time in stable relapsing-remitting multiple sclerosis: a 3-year pilot study. J Neurol Sci 2010; 297: 76-81.
10. Ceccarelli A, Rocca MA, Neema M, et al. Deep gray matter T2 hypointensity is present in patients with clinically isolated syndromes suggestive of multiple sclerosis. Mult Scler 2010; 16: 39-44.
11. Pawate S, Wang L, Song Y, et al. Analysis of T2 intensity by magnetic resonance imaging of deep gray matter nuclei in multiple sclerosis patients: effect of immunomodulatory therapies. J Neuroimaging 2011; 22: 137-144.
12. Lebel RM, Eissa A, Seres P, et al. Quantitative high-field imaging of sub-cortical gray matter in multiple sclerosis. Mult Scler 2012; 18: 433-441.
13. Haacke EM, Cheng NYC, House MJ, et al. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 2005; 23: 1-25.
14. Hammond KE, Metcalf M, Carvajal L, et al. Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron. Ann Neurol 2008; 64: 707-713.
15. Haacke EM, Mittal S, Wu Z, et al. Susceptibility-weighted imaging: technical aspects and clinical applications, part 1. AJNR Am J Neuroradiol 2009; 30: 19-30.
16. Zivadinov R, Heininen-Brown M, Schirda CV, et al. Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case-control study. Neuroimage 2012; 59: 331-339.
17. Wharton S, Schafer A, Bowtell R,. Susceptibility mapping in the human brain using threshold-based k-space division. Magn Reson Med 2010; 63: 1292-1304.
18. Liu T, Spincemaille P, De Rochefort L, et al. Calculation of susceptibility through multiple orientation sampling (COSMOS): a method for conditioning the inverse problem from measured magnetic field map to susceptibility source image in MRI. Magn Reson Med 2009; 61: 196-204.
19. Schweser F, Deistung A, Lehr BW, et al. SEMI-TWInS: Simultaneous extraction of myelin and iron using a T2∗-weighted imaging sequence. Proc. ISMRM 19 2011; 104.
20. Damasceno A, Von Glehn F, Brandao CO, et al. Prognostic indicators for long-term disability in multiple sclerosis patients. J Neurol Sci 2013; 324: 29-33.
21. Al-Radaideh AM, Wharton SJ, Lim S-Y, et al. Increased iron accumulation occurs in the earliest stages of demyelinating disease: an ultra-high field susceptibility mapping study in clinically isolated syndrome. Mult Scler 2012; 19: 896-903.
22. Quinna MP, Gatib JS, Klassenb ML, et al. Increased deep gray matter iron is present in clinically isolated syndromes. Mult Scler Relat Disord (in press).
23. Haacke EM, Garbern J, Miao Y, et al. Iron stores and cerebral veins in MS studied by susceptibility. Int Angiol 2010; 29: 149-157.
24. Chen X, Zeng C, Luo T, et al. Iron deposition of the deep grey matter in patients with multiple sclerosis and neuromyelitis optica: a control quantitative study by 3D-enhanced susceptibility-weighted angiography (ESWAN). Eur J Radiol 2012; 81: e633-e639.
25. Tintore M, Rovira A, Arrambide G, et al. Brainstem lesions in clinically isolated syndromes. Neurology 2010; 75: 1933-1938.
26. Koch M, Mostert J, Heersema D, et al. Tremor in multiple sclerosis. J Neurol 2007; 254: 133-145.
27. Horowski S, Zettl UK, Benecke R, et al. Sonographic basal ganglia alterations are related to non-motor symptoms in multiple sclerosis. J Neurol 2011; 258: 195-202.
28. Fearnley JM, Lees AJ,. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991; 114: 2283-2301.
29. Damier P, Hirsch EC, Agid Y, et al. The substantia nigra of the human brain II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 1999; 122: 1437-1448.
30. Blazejewska AI, Schwarz ST, Pitiot A, et al. Visualization of nigrosome 1 and its loss in PD: Pathoanatomical correlation and in vivo 7 T MRI. Neurology 2013; 81: 534-540.
31. Kwon D-H, Kim J-M, Oh S-H, et al. Seven-Tesla magnetic resonance images of the substantia nigra in Parkinson disease. Ann Neurol 2012; 71: 267-277.
32. Lotfipour AK, Wharton S, Schwarz ST, et al. High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson's disease. J Magn Reson Imaging 2012; 35: 48-55.
33. Minati L, Grisoli M, Carella F, et al. Imaging degeneration of the substantia nigra in Parkinson disease with inversion-recovery. AJNR Am J Neuroradiol 2007; 28: 309-313.
34. Hallgren B, Sourander P,. The effect of age on the non-heamin iron in the human brain. J Neurochem 1958; 3: 41-51.